A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
Olivia Newton-John Cancer Research Institute
City of Hope Medical Center
Mayo Clinic
DL Analytics